Phase 3 Readout
BHC: Phase 3 Topline: RE-AHFIRM (RandomizEd Study of Larsucosterol in Alcohol-associated Hepatitis to Confirm saFety and e
February 1, 2028 · larsucosterol. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- February 1, 2028
- Company
- Bausch Health Companies Inc. (BHC)
- Drug
- larsucosterol
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 3 Readout~month
Phase 3 Topline: RE-AHFIRM (RandomizEd Study of Larsucosterol in Alcohol-associated Hepatitis to Confirm saFety and e
- Drug
- larsucosterol
- Indication
- Hepatitis